BPI
TAK icon

BFC Planning, Inc.’s Takeda Pharmaceutical TAK Stock Holding History

BFC Planning, Inc.’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$148K Buy
9,261
+8,274
+838% +$137K 0.01% 1057
2026
Q1 		$18.3K Buy
987
+76
+8% +$1.33K ﹤0.01% 1757
2025
Q4 		$14.2K Buy
911
+45
+5% +$643 ﹤0.01% 1906
2025
Q3 		$12.7K Buy
866
+174
+25% +$2.58K ﹤0.01% 1790
2025
Q2 		$10.7K Buy
692
+224
+48% +$3.31K ﹤0.01% 1767
2025
Q1 		$6.96K Buy
468
+181
+63% +$2.54K ﹤0.01% 1906
2024
Q4 		$3.8K Buy
+287
New +$3.94K ﹤0.01% 2093

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

BFC Planning, Inc.'s TAK Position: Q2 2026 in Review

BFC Planning, Inc. increased its Takeda Pharmaceutical (TAK) stake by 838% in Q2 2026, buying an estimated $137K and bringing the position to 9,261 shares worth $148K. The position accounts for 0.01% of the portfolio, ranked #1057.

BFC Planning, Inc. first reported a position in TAK in Q4 2024 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • BFC Planning, Inc. held 9,261 shares of Takeda Pharmaceutical worth $148K as of Q2 2026.
  • BFC Planning, Inc. bought 8,274 Takeda Pharmaceutical shares in Q2 2026, an estimated $137K.
  • Takeda Pharmaceutical made up 0.01% of BFC Planning, Inc.'s portfolio in Q2 2026, its #1057 holding.
  • BFC Planning, Inc. first reported a position in Takeda Pharmaceutical in Q4 2024 and has held it in 7 quarters since.
  • 382 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on BFC Planning, Inc.'s 13F filing for Q2 2026, filed 29 Oct 2026.